![Prof Peter Jaksch](/assets/asktheexpert/img/jaksch.jpg)
Expert:
Prof Peter Jaksch
Expertise:
- Prof Jaksch has an extensive ECP experience
- He has been PI for multiple clinical trials
- Author of the Prophylactic use of ECP – A Prospective Randomized Single center trial, 2012
- Author of the EU Multicenter retrospective analysis of ECP in CLAD, 2024
Bio:
- Prof Jaksch is the head of Transplant Pulmonology Medical University of Vienna
- With more than 20 years in one of the largest LTx centres worldwide with more than 100 transplants performed per year, he built an excellent network with several TX centres in Europe, USA and Asia conducting a number of single and multicentre studies in the field of LTx. Main indication was CLAD/BOS but in the last 10 years more and more new ECP indications evolved like CNI sparing protocols, use as induction therapy and treatment of donor specific antibodies
- His main clinical research projects deal with immunosuppressive protocols, induction therapy, CLAD and immunomonitoring
- Since 7 years he performed the so called “TX academies” for pulmonologists, surgeons, ICU doctors and other interested specialist about all aspects of lung transplantation with excellent acceptance
- Some new projects he has initiated with different LTx centres in Europe led to scientific papers on LTx in pts after BMT, influence of use of antifibrotic drugs on postTX outcome
- He has roles in National or International Scientific Societies, like International Society for Heart and Lung Transplantation, European Respiratory Society, European Society for Organ Transplantation and Österreichische Gesellschaft für Pulmologie
Request to book a session with Prof Peter Jaksch
To book an appointment, please make sure you are logged in